The Health Ministry released its first COVID-19 management guidelines about a year ago. Policymakers should have waited for the final publication, worked with industry to scale-up production of budesonide, and bolstered supply chains till the final results came in, rather than hastily making recommendations that may trigger panic buying and a crisis for patients who actually need it. Lastly, absence …
President Donald Trump issued a stout defense Tuesday of a disproved use of a malaria drug as a treatment for the coronavirus, hours after social media companies moved to take down videos promoting its use as potentially harmful misinformation. Trump, his son Donald Trump Jr., and others shared video of the event on Facebook and Twitter, prompting both companies to …
A pharmacy tech pours out hydroxychloroquine pills in May. George Frey/AFP/Getty Images The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild symptoms from Covid-19 who were treated early in their infection, according to a study to be published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either …
The Health Ministry on Saturday said the anti-malarial drug hydroxychloroquine should be used as early as possible in the course of coronavirus treatment to achieve any meaningful effects and should be avoided in patients with severe disease. Hydroxychloroquine clinical trials will resume, says WHO A 22-page new, national clinical management protocol provides for the management of COVID-19 cases based on …
